161 related articles for article (PubMed ID: 2059156)
1. Effect of deltamethrin on antipyrine pharmacokinetics and metabolism in rat.
Anadón A; Martinez-Larrañaga MR; Díaz MJ; Bringas P; Fernandez MC
Arch Toxicol; 1991; 65(2):156-9. PubMed ID: 2059156
[TBL] [Abstract][Full Text] [Related]
2. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
Anadón A; Martinez-Larrañaga MR; Fernandez MC; Diaz MJ; Bringas P
Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
[TBL] [Abstract][Full Text] [Related]
3. Differential induction of cytochrome P450 isoforms and peroxisomal proliferation by cyfluthrin in male Wistar rats.
Anadón A; Martínez MA; Martínez M; Castellano V; Ares I; Romero A; Fernández R; Martínez-Larrañaga MR
Toxicol Lett; 2013 Jul; 220(2):135-42. PubMed ID: 23639246
[TBL] [Abstract][Full Text] [Related]
4. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
5. Effects of flumethrin on hepatic drug-metabolizing enzymes and antipyrine disposition in rats.
Anadón A; Martinez-Larrañaga MR; Diaz MJ; Bringas P; Fernandez MC; Martinez MA; Fernandez-Cruz ML
Toxicol Appl Pharmacol; 1995 May; 132(1):14-8. PubMed ID: 7747277
[TBL] [Abstract][Full Text] [Related]
6. The effects of encainide versus diltiazem on the oxidative metabolic pathways of antipyrine.
Bottorff MB; Lalonde RL; Kazierad DJ; Hoon TJ; Tsiu SJ; Mirvis DM
Pharmacotherapy; 1989; 9(5):315-21. PubMed ID: 2510135
[TBL] [Abstract][Full Text] [Related]
7. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
Loft S; Nielsen AJ; Borg BE; Poulsen HE
Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
[TBL] [Abstract][Full Text] [Related]
8. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
[TBL] [Abstract][Full Text] [Related]
9. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
Adedoyin A; Aarons L; Houston JB
Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
[TBL] [Abstract][Full Text] [Related]
11. Microsomal enzyme induction by permethrin in rats.
Anadon A; Diez MJ; Sierra M; Sanchez JA; Teran MT
Vet Hum Toxicol; 1988 Aug; 30(4):309-12. PubMed ID: 2902710
[TBL] [Abstract][Full Text] [Related]
12. The effect of malaria infection on antipyrine metabolite formation in the rat.
Mansor SM; Ward SA; Edwards G
Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102
[TBL] [Abstract][Full Text] [Related]
13. The effect of intravenous pretreatment with small liposomes on the pharmacokinetics and metabolism of antipyrine in rabbits.
Badiola N; Al-Angary AN; Halbert GW
J Pharm Pharmacol; 1992 Apr; 44(4):366-8. PubMed ID: 1355554
[TBL] [Abstract][Full Text] [Related]
14. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
15. Dextromethorphan pretreatment induces antipyrine clearance in the rat.
Svensson CK; Ware JA
Pharm Res; 1988 Jul; 5(7):437-9. PubMed ID: 3247313
[TBL] [Abstract][Full Text] [Related]
16. The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
van Bezooijen CF; van Oorschot RM
J Pharmacol Exp Ther; 1989 Nov; 251(2):683-6. PubMed ID: 2810117
[TBL] [Abstract][Full Text] [Related]
17. Influence of liver damage on antipyrine metabolite formation in rats.
Tanaka E; Etoh H; Ishikawa A; Nakano M; Misawa S
Xenobiotica; 1991 May; 21(5):663-7. PubMed ID: 1949899
[TBL] [Abstract][Full Text] [Related]
18. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
[TBL] [Abstract][Full Text] [Related]
19. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
Danhof M; Krom DP; Breimer DD
Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
